SCHEDULE 13D

Company

Enveric Biosciences, Inc.

Filed

June 3, 2015

Accession Number

0000921895-15-001545

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →